You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佐力藥業(300181.SZ):一季度淨利潤預增52.98%-62.12%
格隆匯 03-09 19:13

格隆匯3月9日丨佐力藥業(300181.SZ)公佈2022年第一季度業績預吿,公司預計實現2021年度歸屬於上市公司股東的淨利潤為6700.00萬元-7100.00萬元,同比增長52.98%-62.12%;預計實現扣除非經常性損益後的淨利潤為6590.00萬元-7010.00萬元,同比增長:52.25%-61.95%。

業績變動原因系:

1、報吿期內,公司主營產品烏靈膠囊、百令片、靈澤片的營業收入均實現了較快增長。

2、報吿期內,隨着公司盈利能力的提升,公司的資金量更充裕,貸款規模有所降低,財務費用較去年同期降低。

3、報吿期內,非經常性損益對公司淨利潤的影響金額約為90-110萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account